Oncotelic Therapeutics Inc (OTLC)
0.038
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Oncotelic Therapeutics Total Assets (Quarterly): 29.97M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 29.97M |
| December 31, 2023 | 30.02M |
| September 30, 2023 | 30.10M |
| June 30, 2023 | 30.01M |
| March 31, 2023 | 36.05M |
| December 31, 2022 | 36.12M |
| September 30, 2022 | 40.24M |
| June 30, 2022 | 40.39M |
| March 31, 2022 | 23.13M |
| December 31, 2021 | 23.61M |
| September 30, 2021 | 23.19M |
| June 30, 2021 | 23.71M |
| March 31, 2021 | 23.99M |
| December 31, 2020 | 23.66M |
| September 30, 2020 | 24.63M |
| June 30, 2020 | 24.01M |
| March 31, 2020 | 23.60M |
| December 31, 2019 | 23.68M |
| September 30, 2019 | 7.529M |
| June 30, 2019 | 7.660M |
| March 31, 2019 | 0.391M |
| December 31, 2018 | 0.799M |
| September 30, 2018 | 1.149M |
| June 30, 2018 | 2.099M |
| March 31, 2018 | 0.437M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.172M |
| September 30, 2017 | 2.975M |
| June 30, 2017 | 6.529M |
| March 31, 2017 | 10.18M |
| December 31, 2016 | 14.11M |
| September 30, 2016 | 17.26M |
| June 30, 2016 | 20.43M |
| March 31, 2016 | 24.24M |
| December 31, 2015 | 27.45M |
| September 30, 2015 | 30.74M |
| June 30, 2015 | 33.64M |
| March 31, 2015 | 36.56M |
| December 31, 2014 | 30.42M |
| September 30, 2014 | 33.25M |
| June 30, 2014 | 36.85M |
| March 31, 2014 | 25.25M |
| December 31, 2013 | 7.294M |
| September 30, 2013 | 9.221M |
| June 30, 2013 | 8.305M |
| March 31, 2013 | 5.182M |
| December 31, 2012 | 5.447M |
| September 30, 2012 | 6.867M |
| June 30, 2012 | 7.736M |
| March 31, 2012 | 8.988M |
| December 31, 2011 | 11.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
7.529M
Minimum
Sep 2019
40.39M
Maximum
Jun 2022
26.26M
Average
24.00M
Median
Total Assets (Quarterly) Benchmarks
| Mosaic ImmunoEngineering Inc | 0.1795M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 48.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.72M |
| Shareholders Equity (Quarterly) | 11.83M |